Therefore, the inhibition of hepatocyte GSDMD had a greater protective effect on endotoxemia than did hepatocyte-specific Hmgb1 knockout, and other factors that are released may depend on hepatocyte GSDMD activation and have a lethal effect on endotoxemia. The gene discussed is GSDMD; the disease is serum lipopolysaccharide activity.